Back to News
Market Impact: 0.15
CWCI Finds That Meloxicam Has Emerged as California Workers’ Comp Cost Driver
Source: Business Wire
Healthcare & Biotech
Average meloxicam payments in California workers’ compensation rose sharply, and the drug accounted for more than 30% of anti-inflammatory drug spending in 2025. The article provides no exact payment growth rate or dollar amount.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
More News
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock
- Novo raises full-year outlook as Wegovy sales impress
- Sight Sciences earnings missed by $0.48, revenue topped estimates
- Novo CEO Doustdar 'Very Optimistic' About CagriSema